Identifying key regulatory genes in the whole blood of septic patients to monitor underlying immune dysfunctions

Shock

Volumn 40, Issue 3, 2013, Pages 166-174

  Parnell, Grant P ^a,b   Tang, Benjamin M ^a   Nalos, Marek ^a   Armstrong, Nicola J ^c   Huang, Stephen J ^a   Booth, David R ^b   McLean, Anthony S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Gene expression; Immune system; Immunosuppression; Lymphopenia; Sepsis

Indexed keywords

RNA;

ADULT; ANALYTIC METHOD; ANTIGEN PRESENTATION; ARTICLE; B LYMPHOCYTE; BLOOD; BONE MARROW CELL; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DISEASE MARKER; DISEASE SEVERITY; FEMALE; GENE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOCOMPATIBILITY COMPLEX; HUMAN; HUMAN CELL; IMMUNE CELL DECONVOLUTION; IMMUNE DYSREGULATION; IMMUNE RESPONSE; IMMUNE RESPONSE GENE; IMMUNOCOMPETENT CELL; IMMUNOSUPPRESSIVE TREATMENT; INTENSIVE CARE UNIT; LYMPHOCYTE COUNT; LYMPHOCYTE DEPLETION; MALE; MICROARRAY ANALYSIS; NATURAL KILLER CELL; NEUTROPHIL; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; REGULATOR GENE; REGULATORY MECHANISM; RNA SEQUENCE; SEPSIS; SURVIVOR; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

ADULT; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SEPSIS;

EID: 84883303075     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e31829ee604     Document Type: Article

References (31)

1. Boomer JS, To K, Chang KC, Takasu O, Osborne DF, Walton AH, Bricker TL, Jarman SD 2nd, Kreisel D, Krupnick AS, et al.: Immunosuppression in patients who die of sepsis and multiple organ failure. JAMA 306:2594Y2605, 2011.
2. Hotchkiss RS, Tinsley KW, Swanson PE, Schmieg RE Jr, Hui JJ, Chang KC, Osborne DF, Freeman BD, Cobb JP, Buchman TG, et al.: Sepsis-induced apoptosis causes progressive profound depletion of B and CD4+ T lymphocytes in humans. J Immunol 166:6952Y6963, 2001.
3. Hotchkiss RS, Opal S: Immunotherapy for sepsisVa new approach against an ancient foe. N Engl J Med 363:87Y89, 2010.
4. Meisel C, Schefold JC, Pschowski R, Baumann T, Hetzger K, Gregor J,Weber-Carstens S, Hasper D, Keh D, Zuckermann H, et al.: Granulocyte- macrophage colony-stimulating factor to reverse sepsis-associated immunosuppression: a double-blind, randomized, placebo-controlled multicenter trial. Am J Respir Crit Care Med 180:640Y648, 2009.
5. Leentjens J, Kox M, Koch RM, Preijers F, Joosten LA, van der Hoeven JG, Netea MG, Pickkers P: Reversal of immunoparalysis in humans in vivo: a double-blind, placebo-controlled, randomized pilot study. Am J Respir Crit Care Med 186:838Y845, 2012.
6. Ditschkowski M, Kreuzfelder E, Rebmann V, Ferencik S, Majetschak M, Schmid EN, Obertacke U, Hirche H, Schade UF, Grosse-Wilde H: HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg 229:246Y254, 1999.
7. Ertel W, Kremer JP, Kenney J, Steckholzer U, Jarrar D, Trentz O, Schildberg FW: Downregulation of proinflammatory cytokine release in whole blood from septic patients. Blood 85:1341Y1347, 1995.
8. Monneret G, Debard AL, Venet F, Bohe J, Hequet O, Bienvenu J, Lepape A: Marked elevation of human circulating CD4+CD25+ regulatory T cells in sepsis-induced immunoparalysis. Crit Care Med 31:2068Y2071, 2003.
9. Brudecki L, Ferguson DA, McCall CE, El Gazzar M: Myeloid-derived suppressor cells evolve during sepsis and can enhance or attenuate the systemic inflammatory response. Infect Immun 80:2026Y2034, 2012.
10. Ferguson NR, Galley HF, Webster NR: T helper cell subset ratios in patients with severe sepsis. Intensive Care Med 25:106Y109, 1999.
11. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 29:530Y538, 2003.
12. Knaus WA, Draper EA, Wagner DP, Zimmerman JE: APACHE II: a severity of disease classification system. Crit Care Med 13:818Y829, 1985.
13. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, Brown PO: Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci U S A 100:1896Y1901, 2003.
14. Parnell G, McLean A, Booth D, Armstrong N, Nalos M, Huang S, Manak J, Tang W, Tam O, Chan S, et al.: A distinct influenza infection signature in the blood transcriptome of patients who presented with severe community acquired pneumonia. Crit Care 16:R157, 2012.
15. Heng TS, Painter MW: The Immunological Genome Project: networks of gene expression in immune cells. Nat Immunol 9:1091Y1094, 2008.
16. Trapnell C, Pachter L, Salzberg SL: TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25:1105Y1111, 2009.
17. Deng N, Puetter A, Zhang K, Johnson K, Zhao Z, Taylor C, Flemington EK, Zhu D: Isoform-level microRNA-155 target prediction using RNA-seq. Nucleic Acids Res 39:e61, 2011.
18. Xu G, Deng N, Zhao Z, Judeh T, Flemington E, Zhu D: SAMMate: a GUI tool for processing short read alignments in SAM/BAM format. Source Code Biol Med 6:2, 2011.
19. Dahn MS, Whitcomb MP, Lange MP, Jacobs LA: Altered T-lymphocyte subsets in severe sepsis. Am Surg 54:450Y455, 1988.
20. Venet F, Davin F, Guignant C, Larue A, Cazalis MA, Darbon R, Allombert C, Mougin B, Malcus C, Poitevin-Later F, et al.: Early assessment of leukocyte alterations at diagnosis of septic shock. Shock 34:358Y363, 2010.
21. Le Tulzo Y, Pangault C, Gacouin A, Guilloux V, Tribut O, Amiot L, Tattevin P, Thomas R, Fauchet R, Drenou B: Early circulating lymphocyte apoptosis in human septic shock is associated with poor outcome. Shock 18:487Y494, 2002.
22. Gandhi KS, McKay FC, Cox M, Riveros C, Armstrong N, Heard RN, Vucic S, Williams DW, Stankovich J, Brown M, et al.: The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis. Hum Mol Genet 19:2134Y2143, 2010.
23. Gentile LF, Cuenca AG, Efron PA, Ang D, Bihorac A, McKinley BA, Moldawer LL, Moore FA: Persistent inflammation and immunosuppression: a common syndrome and new horizon for surgical intensive care. J Trauma Acute Care Surg 72:1491Y1501, 2012.
24. Hotchkiss RS, Monneret G, Payen D: Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach. Lancet Infect Dis 13:260Y268, 2013.
25. Wong HR, Cvijanovich N, Lin R, Allen GL, Thomas NJ,Willson DF, Freishtat RJ, Anas N, Meyer K, Checchia PA, et al.: Identification of pediatric septic shock subclasses based on genome-wide expression profiling. BMC Med 7:34, 2009.
26. McDunn JE, Husain KD, Polpitiya AD, Burykin A, Ruan J, Li Q, Schierding W, Lin N, Dixon D, Zhang W, et al.: Plasticity of the systemic inflammatory response to acute infection during critical illness: development of the riboleukogram. PLoS ONE 3:e1564, 2008.
27. Textoris J, Loriod B, Benayoun L, Gourraud PA, Puthier D, Albanese J, Mantz J, Martin C, Nguyen C, Leone M: An evaluation of the role of gene expression in the prediction and diagnosis of ventilator-associated pneumonia. Anesthesiology 115:344Y352, 2011.
28. Warren HS, Elson CM, Hayden DL, Schoenfeld DA, Cobb JP, Maier RV, Moldawer LL, Moore EE, Harbrecht BG, Pelak K, et al.: A genomic score prognostic of outcome in trauma patients. Mol Med 15:220Y227, 2009.
29. Wong HR: Clinical review: sepsis and septic shockYthe potential of gene arrays. Crit Care 16:204, 2012.
30. Jones AE, Trzeciak S, Kline JA: The Sequential Organ Failure Assessment score for predicting outcome in patients with severe sepsis and evidence of hypoperfusion at the time of emergency department presentation. Crit Care Med 37:1649Y1654, 2009.
31. Mikkelsen ME, Miltiades AN, Gaieski DF, Goyal M, Fuchs BD, Shah CV, Bellamy SL, Christie JD: Serum lactate is associated with mortality in severe sepsis independent of organ failure and shock. Crit Care Med 37:1670Y1677, 2009.